메타콜린 기관지유발검사의 세 프로토콜 비교
Comparison of 3 protocols in the methacholine bronchial provocation test
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: In Korea, KoKo dosimetry and Aerosol Provocation System (APS) are used in the methacholine provocation test (MBPT). In this study, three protocols of the MBPT were compared. Methods: In patients showing a positive MBPT using short 2-concentration methods for APS with cumulative provocative doses of methacholine which results in a 20% fall in forced expiratory volume in 1 second (FEV1) (PD20) ≤962.81, the MBPT was repeated, using 14-breaths methods for APS. In them, PD20 of those 2 protocols were compared to each other. Provocative concentration of methacholine which results in a 20% fall in FEV1 (PC20) in 14-breaths methods was also compared with that of 5-breaths methods in other patients showing a positive MBPT with KoKo dosimettry during the study period. Results: The positive rate in short 2-concentration methods was 18.1% (43 of 238), while that in 5-breaths methods was 14.0% (6 of 43). They were not different from each other (P=0.342). In 7 patients who underwent the MBPT twice, using short 2-concentration and subsequent 14-breaths methods. The median of PD20 with a positive MBPT using short 2-concentration methods was 573.8 μg with interquartile range (IQR) of 147.8–682.3 μg, whereas that in repeated MBPT using 14-breaths methods was 526.4 μg (IQR, 95.0– 907.1 μg). They did not differ from each other (P=0.735). The median of PC20 in MBPT using 14-breaths methods was 4.76 mg/mL (IQR, 0.066–10.3 mg/mL) tended to be higher than that in other 6 patients who showed a positive MBPT using 5-breaths methods, 1.95 mg/mL (IQR, 0.42–4.85 mg/mL), but it was not significant (P=0.534). Conclusion: Bronchial hyperresponsiveness was not different in 3 protocols of MBPT.
Abstract
Purpose: In Korea, KoKo dosimetry and Aerosol Provocation System (APS) are used in the methacholine provocation test (MBPT). In this study, three protocols of the MBPT were compared. Methods: In patients showing a positive MBPT using short 2-concentration methods for APS with cumulative provocative doses of methacholine which results in a 20% fall in forced expiratory volume in 1 second (FEV1) (PD20) ≤962.81, the MBPT was repeated, using 14-breaths methods for APS. In them, PD20 of those 2 protocols were compared to each other. Provocative concentration of methacholine which results in a 20% fall in FEV1 (PC20) in 14-breaths methods was also compared with that of 5-breaths methods in other patients showing a positive MBPT with KoKo dosimettry during the study period. Results: The positive rate in short 2-concentration methods was 18.1% (43 of 238), while that in 5-breaths methods was 14.0% (6 of 43). They were not different from each other (P=0.342). In 7 patients who underwent the MBPT twice, using short 2-concentration and subsequent 14-breaths methods. The median of PD20 with a positive MBPT using short 2-concentration methods was 573.8 μg with interquartile range (IQR) of 147.8–682.3 μg, whereas that in repeated MBPT using 14-breaths methods was 526.4 μg (IQR, 95.0– 907.1 μg). They did not differ from each other (P=0.735). The median of PC20 in MBPT using 14-breaths methods was 4.76 mg/mL (IQR, 0.066–10.3 mg/mL) tended to be higher than that in other 6 patients who showed a positive MBPT using 5-breaths methods, 1.95 mg/mL (IQR, 0.42–4.85 mg/mL), but it was not significant (P=0.534). Conclusion: Bronchial hyperresponsiveness was not different in 3 protocols of MBPT.
참고문헌 (15)
- Sohn KH, "Report on the methacholine bronchial provocation test protocol : an updated statement of Korean Academy of Asthma, Allergy and Clinical Immunology", Allergy Asthma Respir Dis, 11, pp.56~62 (2023)
- McCracken JL, "Diagnosis and management of asthma in adults : a review", JAMA, 318, pp.279~290 (2017)
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- Prieto L, "Differences in the response to methacholine between the tidal breathing and dosimeter methods : influence of the dose of bronchoconstrictor agent delivered to the mouth", Chest, 134, pp.699~703 (2008)
- Cockcroft DW, "Methacholine challenge : comparison of two methods", Chest, 127, pp.839~844 (2005)
- Cockcroft DW, "The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result", J Allergy Clin Immunol, 117, pp.1244~1248 (2006)
- Coates AL, "ERS technical standard on bronchial challenge testing : general considerations and performance of methacholine challenge tests", Eur Respir J, 49, pp.1601526~ (2017)
- Coates AL, "The PD(20)but not the PC(20)in a methacholine challenge test is device independent", Ann Allergy Asthma Immunol, 118, pp.508~509 (2017)
- Dell SD, "Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers", Ann Am Thorac Soc, 12, pp.357~363 (2015)
- Coates AL, "Developing alternative delivery systems for methacholine challenge tests", J Aerosol Med Pulm Drug Deliv, 27, pp.66~70 (2014)
- Merget R, "Development of a 1-concentration-4-step dosimeter protocol for methacholine testing", Respir Med, 103, pp.607~613 (2009)
- Schulze J, "Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique", Respir Med, 103, pp.1898~1903 (2009)
- Wegmann M, "Th2 cells as targets for therapeutic intervention in allergic bronchial asthma", Expert Rev Mol Diagn, 9, pp.85~100 (2009)
- Hvidtfeldt M, "Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes", J Allergy Clin Immunol, 152, pp.107~116 (2023)
- Andreasson LM, "Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation", J Allergy Clin Immunol, 153, pp.988~997 (2024)